Sionna Therapeutics
Sionna Therapeutics is a clinical-stage life sciences company focused on developing treatments for cystic fibrosis (CF). They are developing small molecules to fully restore the function of the CFTR protein, aiming to provide highly effective and differentiated CF treatments. Their pipeline includes NBD1 stabilizers and complementary modulators targeting ICL4.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $182M
Date: 06-Mar-2024
Investors: Enavate Sciences, Viking Global Investors, Perceptive Advisors, RA Capital, OrbiMed, TPG's The Rise Fund, Atlas Venture, the Cystic Fibrosis Foundation, funds and accounts advised by T. Rowe Price Associates, Inc., Q Healthcare Holdings, LLC
Markets: Life Sciences, Biotechnology, Pharmaceuticals
HQ: Boston, Massachusetts, United States
Founded: 2019
Website: https://www.sionnatx.com/
LinkedIn: https://www.linkedin.com/company/sionna-therapeutics
Twitter: https://twitter.com/sionna_tx
Crunchbase: https://www.crunchbase.com/organization/sionna-therapeutics
Leave a Comment
Comments
No comments yet.